Brad Doerschuk

Brad Doerschuk, President / CEO

A passionate, visionary, proven leader at all levels of clinical development, Brad founded PharmaMed Research in 2001 prior to co-founding InFocus Clinical in partnership with USRetina – the leading alliance of retina specialists. A 2012 PharmaVoice 100 recipient with a 20 year history of leadership in development of landmark products including Tamiflu, Pegasys, Provenge and many others, Brad has a proven ability to connect with all levels of a clinical development program. Brad has a penchant for merging best practices to forge uncanny efficiency, productivity, teamwork, commitment, superior trial enrollment and execution. Brad has led successful development programs with small, focused, single-compound companies as well as critical large-scale development programs with some of the largest pharmaceutical companies.